Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib-Therapie

被引：0

作者：

Jonas, Caroline ^{[1
]}

Schoen, Michael P. ^{[1
]}

Moessner, Rotraut ^{[1
]}

机构：

[1] Univ Med Gottingen, Klin Dermatol Venerol & Allergol, Robert Koch Str 40, D-37075 Gottingen, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2025年 / 23卷 / 02期

关键词：

D O I：

10.1111/ddg.15603_g

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：234 / 236

页数：3

共 7 条

[1]

Eichner Adina, 2022, J Dtsch Dermatol Ges, V20, P1621, DOI [10.1111/ddg.14885_g, 10.1111/ddg.14885]

[2]

Eichner Adina, 2022, J Dtsch Dermatol Ges, V20, P1485, DOI 10.1111/ddg.14921_g

[3] Association between psoriasis and alopecia areata: A systematic review and meta-analysis [J].

Jung, Joon Min ;

Yang, Hee Joo ;

Lee, Woo Jin ;

Won, Chong Hyun ;

Lee, Mi Woo ;

Chang, Sung Eun .

JOURNAL OF DERMATOLOGY, 2022, :912-915

[4] Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis [J].

Lee, Harrison H. ;

Gwillim, Eran ;

Patel, Kevin R. ;

Hua, Tammy ;

Rastogi, Supriya ;

Ibler, Erin ;

Silverberg, Jonathan, I .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (03) :675-682

[5] Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report [J].

Oliel, Sarah ;

Moussa, Sarah ;

Stanciu, Monica ;

Netchiporouk, Elena .

SAGE OPEN MEDICAL CASE REPORTS, 2023, 11

[6] Which is the ideal JAK inhibitor for alopecia areata - Baricitinib, tofacitinib, ritlecitinib or ifidancitinib-Revisiting the immunomechanisms of the JAK pathway [J].

Sardana, Kabir ;

Bathula, Savitha ;

Khurana, Ananta .

INDIAN DERMATOLOGY ONLINE JOURNAL, 2023, 14 (04) :465-474

[7] Successful treatment of alopecia universalis with abrocitinib: a case report [J].

Zhang, Jie ;

Zuo, Ya-Gang .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)

← 1 →